Glucocorticoid-induced diabetes
Ugeskrift for Læger · 22.06.2026 · 1-8
DOI: 10.61409/v09250780 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, online erschienen am 22.06.2026. Verfasst von Rasmus Fuglsang-Nielsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicinsk Afdeling, Regionshospitalet Horsens. Hauptthemen laut MEDLINE: Glucocorticoids, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Glucocorticoid-induced diabetes (GID) is a frequent and serious side effect of glucocorticoid treatment. Its distinct glucose profile – characterised by afternoon/evening postprandial hyperglycemia and often normal fasting blood sugar – necessitates a tailored treatment approach. Effective management requires proactive risk stratification, targeted screening, and early intervention to mitigate serious complications like increased mortality, cardiovascular events, and infections, as argued in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medicinsk Afdeling, Regionshospitalet Horsens.
- Steno Diabetes Center Copenhagen, Københavns Universitetshospital.
- Klinik for Hormon- og Knoglesygdomme, Aarhus Universitetshospital.
- Steno Diabetes Center Aarhus, Aarhus Universitetshospital.
Zitieren
APA
Fuglsang-Nielsen, R., Hansen, K. B., Bengtsen, M. B., & Søndergaard, E. (2026). Glucocorticoid-induced diabetes. Ugeskrift for Læger, 1-8. https://doi.org/10.61409/v09250780
Vancouver
Fuglsang-Nielsen R, Hansen KB, Bengtsen MB, Søndergaard E. Glucocorticoid-induced diabetes. Ugeskrift for Læger. 2026:1-8. doi:10.61409/v09250780
BibTeX
@article{FuglsangNielsen2026,
author = {Fuglsang-Nielsen, Rasmus and Hansen, Katrine Bagge and Bengtsen, Mads Bisgaard and Søndergaard, Esben},
title = {Glucocorticoid-induced diabetes},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--8},
doi = {10.61409/v09250780}
}
EUVIMED